IDEXX Laboratories

World Rank (Jul-30-2023)
386
Market Cap (Jul-30-2023)
45.883 Billion USD
World Rank (Dec-25-2022)
498
Market Cap (Dec-25-2022)
34.003 Billion USD
World Rank (Jan-07-2022)
415
Market Cap (Jan-07-2022)
46.662 Billion USD
World Rank (Jan-01-2021)
395
Market Cap (Jan-01-2021)
42.639 Billion USD
Company Rank in Country in 2023
Company Rank in USA in July-2023 is 188
Annual Revenue in USD
3,367 Million USD
Annual Net Income in USD
679 Million USD
Total Assets in USD
2,746 Million USD
Total Liabilities in USD
2,138 Million USD
Annual Results for Year ending in
Dec-2022 month
Headquarters State / City
Maine
Headquarters Country
USA
Company Business
Healthcare
HealthCare Products
Pharmaceutical
Animal Health Medicine
Animal Healthcare Companies
Stock Category
S&P 500
Nasdaq 100
Stock Exchange
Nasdaq
Company Rank in Country in 2022
Company Rank in USA in 2022 is 187
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 177
Rank in Country (Jan-2020)
Rank in USA in 2020 is 301
Number of Employees
10,780
Employee Count as on Date
As on 2022
Chairman
Jonathan W. Ayers
CEO:
Jay Mazelsky
Yahoo
Yahoo @ Nasdaq
Wikipedia
Wikipedia
Facebook
Facebook
Company Website:
Idexx - Animal Healthcare Company
About Company Business:

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world. Headquarters is in USA. 

Idexx is animal healthcare company and they have over 7,000 employees across 175 countries.

Idexx Laboratories engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.

Idexx have board-certified veterinary specialists and pathologists and they early detect issues and health disorders in animals.

As on 2022, IDEXX Laboratories, Inc. has 10,780 employees.

IDEXX Laboratories, Inc. annual revenue generated for period ending Dec-2022 was 3,367 million USD.

IDEXX Laboratories, Inc. annual net income generated for period ending Dec-2022 was 679 million USD.

IDEXX Laboratories annual revenue generated for period ending Dec-2021 was 3,215 million USD.

IDEXX Laboratories annual net income generated for period ending Dec-2021 was 744 million USD.

IPO Year
1991
Founded Year
1983
Annual Results Summary:

IDEXX LABORATORIES - Annual Result Summary - in Million USD

Year Ending: Total Revenue Operating Income Net Income
Dec-2022 3,367 898 679
Dec-2021 3,215 932 744
Dec-2020 2,706 694 582
Dec-2019 2,407 553 428
Dec-2018 2,213 491 377
Dec-2017 1,969 413 263
Dec-2016 1,775 350 222
Balance Sheet Summary

IDEXX LABORATORIES - Balance Sheet Summary - in Million USD

Year Ending:

 Total Assets Total Liabilities Total Equity
Dec-2022 2,746 2,138 608
Dec-2021 2,437 1,747 690
Dec-2020 2,295 1,662 632
Dec-2019 1,832 1,655 177
Dec-2018 1,537 1,547 -10
Dec-2017 1,713 1,768 -54
Quarterly Results Summary:

IDEXX LABORATORIES - Quarterly Result Summary - in Million USD

Quarterly Ending:

 Total Revenue Operating Income Net Income
Sep-2023 915 275 212
Jun-2023 943 296 224
Mar-2023 900 280 214
Dec-2022 828 226 172
Sep-2022 841 244 180
Jun-2022 860 179 131
Mar-2022 836 248 193
Dec-2021 801 199 162
Sep-2021 810 226 175
Jun-2021 826 259 203
Mar-2021 778 248 204
Dec-2020 721 185 175
Institutional Investors

Top 30 Institutional Holder Names in IDEXX LABORATORIES as on SEP-30-2023

RANK INSTITUTION NAME DATE SHARES HELD CHANGE (SHARES) CHANGE (%) VALUE (IN 1,000S)
1 BLACKROCK INC. 09/30/2023 86,34,291 -14,459 -0.17% $4,029,106
2 VANGUARD GROUP INC 09/30/2023 82,60,460 14,365 0.17% $3,854,661
3 STATE STREET CORP 09/30/2023 37,62,070 -9,504 -0.25% $1,755,532
4 ALLIANCEBERNSTEIN L.P. 09/30/2023 33,26,016 -2,66,816 -7.43% $1,552,052
5 FUNDSMITH LLP 09/30/2023 29,64,554 3,003 0.10% $1,383,379
6 BAMCO INC /NY/ 09/30/2023 23,36,330 -40,302 -1.70% $1,090,225
7 GEODE CAPITAL MANAGEMENT, LLC 09/30/2023 20,64,139 51,140 2.54% $963,210
8 FRANKLIN RESOURCES INC 09/30/2023 13,77,349 -69,666 -4.81% $642,726
9 INVESCO LTD. 09/30/2023 12,16,978 -19,107 -1.55% $567,891
10 BLAIR WILLIAM & CO/IL 09/30/2023 11,99,945 7,812 0.66% $559,942
11 BROWN ADVISORY INC 09/30/2023 11,61,124 24,741 2.18% $541,827
12 MORGAN STANLEY 09/30/2023 10,64,514 48,095 4.73% $496,745
13 CAPITAL WORLD INVESTORS 09/30/2023 10,11,327 4,254 0.42% $471,926
14 FUNDSMITH INVESTMENT SERVICES LTD. 09/30/2023 9,89,592 -29,936 -2.94% $461,783
15 GQG PARTNERS LLC 09/30/2023 9,31,886 9,31,886 New $434,855
16 NORTHERN TRUST CORP 09/30/2023 9,19,191 65,891 7.72% $428,931
17 NORGES BANK 12/31/2022 8,24,629 35,899 4.55% $384,805
18 PRINCIPAL FINANCIAL GROUP INC 09/30/2023 8,15,863 11,315 1.41% $380,714
19 JPMORGAN CHASE & CO 09/30/2023 8,01,274 65,760 8.94% $373,906
20 BANK OF AMERICA CORP /DE/ 09/30/2023 7,95,957 1,27,793 19.13% $371,425
21 AMERICAN CENTURY COMPANIES INC 09/30/2023 7,34,707 -1,03,948 -12.40% $342,844
22 WINSLOW CAPITAL MANAGEMENT, LLC 09/30/2023 6,89,873 1,37,621 24.92% $321,922
23 LEGAL & GENERAL GROUP PLC 09/30/2023 6,72,039 -22,921 -3.30% $313,600
24 BANK OF NEW YORK MELLON CORP 09/30/2023 6,61,371 -4,684 -0.70% $308,622
25 AMUNDI 09/30/2023 6,12,065 29,589 5.08% $285,614
26 GOLDMAN SACHS GROUP INC 09/30/2023 5,42,236 44,395 8.92% $253,029
27 UBS ASSET MANAGEMENT AMERICAS INC 09/30/2023 5,04,789 87,185 20.88% $235,555
28 NEUBERGER BERMAN GROUP LLC 09/30/2023 4,87,846 -7,221 -1.46% $227,648
29 CAPITAL COUNSEL LLC/NY 09/30/2023 4,72,270 -727 -0.15% $220,380
30 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 09/30/2023 4,62,535 5,044 1.10% $215,837

Share it on Social Media